87 related articles for article (PubMed ID: 11642327)
21. Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?
Kinzig-Schippers M; Tomalik-Scharte D; Jetter A; Scheidel B; Jakob V; Rodamer M; Cascorbi I; Doroshyenko O; Sörgel F; Fuhr U
Antimicrob Agents Chemother; 2005 May; 49(5):1733-8. PubMed ID: 15855489
[TBL] [Abstract][Full Text] [Related]
22. Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers.
Tokui K; Asai Y; Arakawa T; Matsumoto T; Nabeshima T
Biol Pharm Bull; 2002 Feb; 25(2):264-7. PubMed ID: 11853180
[TBL] [Abstract][Full Text] [Related]
23. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
24. NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus.
Sabbagh N; Delaporte E; Marez D; Lo-Guidice JM; Piette F; Broly F
Pharmacogenetics; 1997 Apr; 7(2):131-5. PubMed ID: 9170150
[TBL] [Abstract][Full Text] [Related]
25. Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration.
Adkison KK; Vaidya SS; Lee DY; Koo SH; Li L; Mehta AA; Gross AS; Polli JW; Humphreys JE; Lou Y; Lee EJ
J Pharm Sci; 2010 Feb; 99(2):1046-62. PubMed ID: 19569219
[TBL] [Abstract][Full Text] [Related]
26. Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.
Han LW; Ryu RJ; Cusumano M; Easterling TR; Phillips BR; Risler LJ; Shen DD; Hebert MF
J Clin Pharmacol; 2019 Dec; 59(12):1678-1689. PubMed ID: 31257615
[TBL] [Abstract][Full Text] [Related]
27. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
Cascorbi I; Brockmöller J; Mrozikiewicz PM; Bauer S; Loddenkemper R; Roots I
Cancer Res; 1996 Sep; 56(17):3961-6. PubMed ID: 8752164
[TBL] [Abstract][Full Text] [Related]
28. Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2.
Kubota R; Ohno M; Hasunuma T; Iijima H; Azuma J
Eur J Clin Pharmacol; 2007 Oct; 63(10):927-33. PubMed ID: 17665185
[TBL] [Abstract][Full Text] [Related]
29. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
[TBL] [Abstract][Full Text] [Related]
30. Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
Gu GZ; Xia HM; Pang ZQ; Liu ZY; Jiang XG; Chen J
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):449-56. PubMed ID: 21251889
[TBL] [Abstract][Full Text] [Related]
31.
Allen CE; Doll MA; Hein DW
Drug Metab Dispos; 2017 Dec; 45(12):1276-1281. PubMed ID: 29018032
[TBL] [Abstract][Full Text] [Related]
32. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
33. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P
Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063
[TBL] [Abstract][Full Text] [Related]
34. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
[TBL] [Abstract][Full Text] [Related]
35. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
[TBL] [Abstract][Full Text] [Related]
36. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
[TBL] [Abstract][Full Text] [Related]
37. Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus.
Mrozikiewicz PM; Drakoulis N; Roots I
Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):626-34. PubMed ID: 7995004
[TBL] [Abstract][Full Text] [Related]
38. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
39. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
40. Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye.
Nohynek GJ; Skare JA; Meuling WJ; Hein DW; De Bie AT; Toutain H
Food Chem Toxicol; 2004 Nov; 42(11):1885-91. PubMed ID: 15350687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
